financetom
Business
financetom
/
Business
/
Hewlett Packard, Juniper Networks to Defend $14-Billion Deal Following US DoJ's Antitrust Lawsuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hewlett Packard, Juniper Networks to Defend $14-Billion Deal Following US DoJ's Antitrust Lawsuit
Jan 30, 2025 11:16 AM

01:56 PM EST, 01/30/2025 (MT Newswires) -- Hewlett Packard Enterprise ( HPE ) and Juniper Networks ( JNPR ) said Thursday they will "vigorously defend" their proposed deal in court following the US Justice Department's decision to file a lawsuit to block the $14 billion transaction on antitrust grounds.

"We believe the Department of Justice's analysis of this acquisition is fundamentally flawed and we are disappointed in its decision to file a suit attempting to prohibit the closing of the transaction," Hewlett Packard ( HPE ) and Juniper Networks ( JNPR ) said in a joint statement.

In a complaint filed Thursday, the DoJ said the proposed deal would increase concentration in the wireless local-area network market and could potentially reduce competition.

Hewlett Packard ( HPE ) and Juniper Networks ( JNPR ) said they would "vigorously defend" against the DoJ's "overreaching interpretation of antitrust laws."

The companies added that they remained fully committed to the deal and believed they would prevail in litigation.

Shares of Hewlett Packard ( HPE ) fell 2.2%, while Juniper Networks ( JNPR ) declined 2.1% in recent trading.

Price: 21.18, Change: -0.48, Percent Change: -2.24

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Abivax Shares Surge After Ulcerative Colitis Treatment Meets Primary Endpoint in Two Phase 3 Trials
Abivax Shares Surge After Ulcerative Colitis Treatment Meets Primary Endpoint in Two Phase 3 Trials
Jul 23, 2025
11:48 AM EDT, 07/23/2025 (MT Newswires) -- Abivax ( ABVX ) shares surged 553% in recent Wednesday trading after the company said its investigational ulcerative colitis drug candidate obefazimod met the primary endpoint of clinical remission in two global phase 3 trials. The 50 mg once-daily dose of obefazimod achieved statistically significant remission at week 8 in both the Abtect-1...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
RBC Previews Canadian Lifecos Q2
RBC Previews Canadian Lifecos Q2
Jul 23, 2025
11:52 AM EDT, 07/23/2025 (MT Newswires) -- The Canadian lifecos begin reporting second quarter results on August 5. RBC has raised core EPS estimates for the group by 0.6% on average. Our tracked funds suggest average retail AUM declines for the group and we expect net retail outflows for all the lifecos in our coverage and while this might have...
Update: IsoEnergy, Purepoint Extend High-Grade Mineralization at Dorado Joint Venture in Saskatchewan
Update: IsoEnergy, Purepoint Extend High-Grade Mineralization at Dorado Joint Venture in Saskatchewan
Jul 23, 2025
11:51 AM EDT, 07/23/2025 (MT Newswires) -- (Adds comment and updates shares.) IsoEnergy ( ISOU ) and Purepoint Uranium Group ( PTUUF ) on Wednesday reported the latest drilling results that extended high-grade mineralization at their Dorado uranium joint venture project in Saskatchewan. The most recent drill hole, PG25-07A, stepped out about 70 meters northeast of the Nova Discovery returned...
Copyright 2023-2026 - www.financetom.com All Rights Reserved